Txhim kho ACE-031

Txhim kho ACE-031

Khoom npe: ACE-031
Cov tsos mob: Dawb khov- cov hmoov qhuav
Purity: 99% +
Yam tsawg kawg nkaus txiav txim: 10 vials/kit
Av / Lub Tebchaws: Shenzhen, Suav

Khoom Taw qhia

ACE-031 yog ib qho kev hloov pauv hloov pauv ntawm ActRIIB receptor fusion protein uas nws qhov kev hloov pauv tseem ceeb nyob hauv kev tsim kho quantum kev sib txuas lus ntawm lub cev musculoskeletal. Nws tus kheej- sib sau ua ke rau hauv nano-decoy network nyob rau hauv lub extracellular matrix, ntes myostatin thiab activin nrog quantum efficiency, reshaping lub spatiotemporal entanglement ntawm mechanical signals thiab biochemical pathways. This not only relieves muscle inhibition but also simultaneously optimizes bone density and tendon adaptability, achieving intelligent repair through multi-tissue synergy.

 

Lub npe

TSW-031

Qhov tshwm sim

Dawb khov- cov hmoov qhuav

Purity

99%+

Yam tsawg kawg nkaus

10 vials/kit

Vaj tse/Nation

Shenzhen, Suav teb

Tau txais txoj kev them nyiaj

BTC / USDT / Lub txhab nyiaj hloov pauv / Western Union

Lub sijhawm thauj mus los

Nyob ib ncig ntawm 10-15 hnub

 

Cov ntsiab lus

ACE-031 yog ib qho recombinant fusion protein tsim los ntawm thaj tsam extracellular ntawm activin receptor IIB (ActRIIB) txuas rau tib neeg IgG1-Fc fragment. Qhov tseem ceeb yog ib qho "decoy receptor", uas tsis yog ib qho me me peptide, nws cov txheej txheem ntawm kev ua yog ntau meej thiab muaj zog, ua rau nws "kev cuam tshuam molecule" hauv kev tswj cov leeg nqaij.

 

Lub cev Mechanism: Precturing "Capturing" Inhibitory Signals, Unlocking Muscle Potential

product-612-408

Nws cov txheej txheem tseem ceeb yog kev sib tw chelation ntawm myosin (GDF-8) thiab lwm yam ligands. Myosin ua "tsis zoo nres" ntawm cov leeg nqaij loj hlob hauv tib neeg lub cev. Los ntawm kev khi rau ActRIIB receptor hauv cov leeg nqaij, nws ua rau txoj kev Smad2/3, inhibiting leeg nqaij protein synthesis thiab txhawb kev degradation. ACE-031 preemptively khi rau circulating myosin, GDF-11, activin A, thiab lwm yam tsis zoo regulators nrog siab affinity, thaiv lawv khi rau cell receptors thiab relieving kev loj hlob inhibition. Cov txheej txheem no ua rau cov leeg nqaij satellite, ua kom myofiber hypertrophy thiab proliferation; ib txhij, nws upregulates lub mTOR thiab Akt txoj kev, txhim kho protein synthesis thiab txo kev puas tsuaj, ua kom tiav ib tug dual kev txhim kho nyob rau hauv cov leeg zoo thiab loj. Tsis tas li ntawd, nws tsis cuam tshuam nrog endocrine axis, suav nrog testosterone thiab qib kev loj hlob hormone, ua haujlwm ntawm nws tus kheej thiab nrog lub hom phiaj muaj zog heev.

Haum rau: Targeting nqaij imbalances thiab hais txog ntau yam kev xav tau

1. Cov neeg mob uas muaj cov leeg nqaij atrophy: Cov tib neeg uas muaj cov leeg mob hnyav vim muaj cov kab mob ntev xws li Duchenne muscular dystrophy, mob cancer cachexia, thiab AIDS tuaj yeem ua rau qeeb ntawm cov leeg nqaij thiab kev txuag lub cev muaj zog.

2. Nruab nrab-hnub nyoog thiab cov neeg laus tiv thaiv- pawg neeg laus: Hais txog sarcopenia (hnub nyoog- cuam tshuam cov leeg nqaij), tswj cov leeg nqaij, pob txha ntom ntom, thiab limb vitality, thiab txhim kho lub neej zoo.

3. Cov kws tshaj lij kev tawm dag zog / cov neeg ncaws pob: tsoo los ntawm cov nqaij pob txha loj hlob hauv lub cev, ua kom lub cev hnyav zuj zus, cov leeg nqaij ntom ntom, thiab lub zog, thiab ua kom lub cev muaj roj ntau ntau.

4. Cov tib neeg nyob rau lub sijhawm rov qab los: Tom qab- kev phais thiab tom qab- mob hnyav yuav tsum tau kho cov nqaij mos thiab cov nqaij mos, ua kom lub sijhawm rov qab los, thiab rov ua haujlwm ntawm ceg ceg.

Core Advantages thiab Limitations

Qhov zoo:Dav -spectrum inhibition, muaj zog cov leeg loj hlob; ib koob tshuaj tuaj yeem nce lub cev hnyav los ntawm 3.3% thiab cov leeg nqaij pob txha los ntawm 5.1% hauv 29 hnub; ntev - kav ntev thiab ruaj khov, nrog ib nrab ntev - lub neej, yuav tsum tau txhaj tshuaj txhua 2-4 lub lis piam; tsis cuam tshuam rau endocrine system, tsis muaj kev pheej hmoo ntawm hormonal tsis txaus.

Kev txwv:Kev txhim kho kev kho mob raug txiav tawm vim yog vascular toxicity (nosebleed, telangiectasia); ntev - siv sij hawm ntev los yog siv ntau dhau yuav ua rau cov leeg mob thiab ua rau muaj kev sib koom ua ke siab; tam sim no tsuas yog siv rau kev tshawb fawb thiab tsis tau txais kev pom zoo los ntawm kws kho mob.

ACE-031, nrog rau nws lub tswv yim "molecular decoy" mechanism, muab cov tshuaj muaj zog rau cov leeg nqaij loj hlob thiab kho, haum rau kev kho kab mob, tiv thaiv kev laus, thiab kev tsim cov leeg los ntawm kev tawm dag zog. Txawm li cas los xij, kev ua raws li cov lus qhia siv yog tsim nyog, thiab cov txiaj ntsig thiab kev pheej hmoo yuav tsum tau ua tib zoo ntsuas.

Cim npe nrov: ace-031, Tuam Tshoj enhanced ace-031 manufacturers, lwm tus neeg, Hoobkas

Xa kev nug

whatsapp

Xov tooj

Tug

Kev nug

hnab